Detalhe da pesquisa
1.
Supporting a review of the benefits package of the National Health Insurance Scheme in Ghana.
Cost Eff Resour Alloc
; 20(1): 32, 2022 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842698
2.
A one stop shop for cost-effectiveness evidence? Recommendations for improving Disease Control Priorities.
Cost Eff Resour Alloc
; 17: 7, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930694
3.
Estimation of Societal Values of Health States Preferences at the National Level for Low- and Middle-Income Countries.
Value Health Reg Issues
; 39: 40-48, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976776
4.
Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds.
Expert Rev Pharmacoecon Outcomes Res
; 24(2): 203-215, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112068
5.
Informing a cost-effectiveness threshold for Saudi Arabia.
J Med Econ
; 26(1): 128-138, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576804
6.
Economic evaluation of self-help group interventions for health in LMICs: a scoping review.
Health Policy Plan
; 38(9): 1033-1049, 2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599510
7.
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment.
Appl Health Econ Health Policy
; 20(1): 13-18, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34467474
8.
Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries.
Health Policy Plan
; 37(1): 45-54, 2022 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34410385
9.
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach.
Appl Health Econ Health Policy
; 20(6): 881-891, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997895
10.
Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates.
Pharmacoeconomics
; 40(1): 31-43, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34585359
11.
Valuing health outcomes: developing better defaults based on health opportunity costs.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 729-736, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32954900
12.
Concomitant health benefits package design and research prioritisation: development of a new approach and an application to Malawi.
BMJ Glob Health
; 6(12)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903565
13.
Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.
Clin Ther
; 42(1): 44-59.e2, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955967
14.
Squaring the cube: Towards an operational model of optimal universal health coverage.
J Health Econ
; 70: 102282, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955865
15.
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries.
BMJ Glob Health
; 5(10)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33082132
16.
Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach.
Pharmacoeconomics
; 38(12): 1319-1331, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856280
17.
What next after GDP-based cost-effectiveness thresholds?
Gates Open Res
; 4: 176, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33575544
18.
Accounting for Timing when Assessing Health-Related Policies.
J Benefit Cost Anal
; 10(Suppl 1): 73-105, 2019 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33282628
19.
Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data.
BMJ Glob Health
; 3(6): e000964, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30483412
20.
Cost-Effectiveness Thresholds: the Past, the Present and the Future.
Pharmacoeconomics
; 36(5): 509-522, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427072